Atlas Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Atlas Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$285.76 - $321.48 $1,143 - $1,285	-4 Reduced 2.41%	162 $46.8 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $547 - $611	2 Added 1.22%	166 $48.1 Million
Q2 2022 Aug 16, 2022	BUY	$234.96 - $292.55 $38,533 - $47,978	164 New	164 $46.2 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $1,107 - $1,304	-5 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$187.49 - $221.1 $937 - $1,105	5 New	5 $1,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.